These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31419433)

  • 81. Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer.
    Rudolph MM; Baur ADJ; Haas M; Cash H; Miller K; Mahjoub S; Hartenstein A; Kaufmann D; Rotzinger R; Lee CH; Asbach P; Hamm B; Penzkofer T
    Eur Radiol; 2020 Aug; 30(8):4262-4271. PubMed ID: 32219507
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
    Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer].
    Qu HW; Liu H; Cui ZL; Jin XB; Zhao Y; Wang MW; Song W; Zhang XJ
    Zhonghua Nan Ke Xue; 2016 Sep; 22(9):782-786. PubMed ID: 29071873
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.
    Kam J; Yuminaga Y; Krelle M; Gavin D; Koschel S; Aluwihare K; Sutherland T; Skinner S; Brennan J; Wong LM; Louie-Johnsun M
    BJU Int; 2019 Aug; 124(2):297-301. PubMed ID: 30714285
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.
    Brizmohun Appayya M; Sidhu HS; Dikaios N; Johnston EW; Simmons LA; Freeman A; Kirkham AP; Ahmed HU; Punwani S
    Br J Radiol; 2018 Feb; 91(1083):20170645. PubMed ID: 29189042
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
    Deniffel D; Perlis N; Ghai S; Girgis S; Healy GM; Fleshner N; Hamilton R; Kulkarni G; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA
    Eur Radiol; 2022 Nov; 32(11):7544-7554. PubMed ID: 35507051
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion-targeted biopsy in patients with a solitary PI-RADS v2-scored lesion.
    Syed JS; Nguyen KA; Nawaf CB; Bhagat AM; Huber S; Levi A; Humphrey P; Weinreb JC; Schulam PG; Sprenkle PC
    Urol Oncol; 2017 Sep; 35(9):542.e19-542.e24. PubMed ID: 28501565
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology.
    Pockros B; Stensland KD; Parries M; Frankenberger E; Canes D; Moinzadeh A
    Prostate; 2022 Feb; 82(3):352-358. PubMed ID: 34878175
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy.
    NiMhurchu E; O'Kelly F; Murphy IG; Lavelle LP; Collins CD; Lennon G; Galvin D; Mulvin D; Quinlan D; McMahon CJ
    Clin Radiol; 2016 Apr; 71(4):375-80. PubMed ID: 26880299
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MRI Fusion-Targeted Transrectal Prostate Biopsy and the Role of Prostate-Specific Antigen Density and Prostate Health Index for the Detection of Clinically Significant Prostate Cancer in Southeast Asian Men.
    Tan TW; Png KS; Lee CH; Yuwono A; Yeow Y; Chong KT; Lee YM; Tan CH; Tan YK
    J Endourol; 2017 Nov; 31(11):1111-1116. PubMed ID: 28797178
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
    Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
    J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [TBL] [Abstract][Full Text] [Related]  

  • 94. In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve.
    Friedl A; Schneeweiss J; Sevcenco S; Eredics K; Kunit T; Susani M; Kivaranovic D; Eisenhuber-Stadler E; Lusuardi L; Brössner C; Schima W
    Urology; 2018 Apr; 114():139-146. PubMed ID: 29330001
    [TBL] [Abstract][Full Text] [Related]  

  • 95. One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis.
    Tafuri A; Ashrafi AN; Palmer S; Shakir A; Cacciamani GE; Iwata A; Iwata T; Cai J; Sali A; Gupta C; Medina LG; Stern MC; Duddalwar V; Aron M; Gill IS; Abreu A
    World J Urol; 2020 Apr; 38(4):949-956. PubMed ID: 31175460
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluating the efficacy of a low-cost cognitive MRI-targeted prostate biopsy protocol: is there still a role for lower volume centers in the Prostate Imaging Reporting and Data System (PI-RADS) version 2 era?
    Takeshima Y; Tanaka Y; Takemura K; Nakazono S; Yamashita E; Kume H
    Int Urol Nephrol; 2020 Nov; 52(11):2043-2050. PubMed ID: 32705477
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Index lesion detection in multifocal prostate cancer: Simplified PI-RADS biparametric MRI vs PI-RADS v2.1 multiparametric MRI.
    Scialpi M; Martorana E; Torre R; Scalera GB; Belatti E; Improta A; Aisa MC; Burani A; Santini N; D'Andrea A; Mancioli FM; Scialpi P; Di Blasi A
    Clin Imaging; 2023 Feb; 94():108-115. PubMed ID: 36527796
    [No Abstract]   [Full Text] [Related]  

  • 99. Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies.
    Kortenbach KC; Løgager V; Thomsen HS; Boesen L
    Abdom Radiol (NY); 2023 Feb; 48(2):688-693. PubMed ID: 36318331
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Efficacy of plasma atherogenic index in predicting malignancy in the presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) prostate lesions.
    Senel S; Ceviz K; Kasap Y; Tastemur S; Olcucuoglu E; Uzun E; Polat ME; Koudonas A; Sarialtin F
    Int Urol Nephrol; 2023 Feb; 55(2):255-261. PubMed ID: 36357644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.